13
Participants
Start Date
January 15, 2020
Primary Completion Date
October 31, 2023
Study Completion Date
October 31, 2023
nivolumab
Specified Dose on Specified Days
Placebo
Specified Dose on Specified Days
Bacillus Calmette-Guérin (BCG)
Specified Dose on Specified Days
Local Institution - 0010, Recoleta
Local Institution - 0099, Vienna
Local Institution - 0080, Buenos Aires
Local Institution - 0088, Capital Federal
Local Institution - 0009, Caba
Local Institution - 0016, Ciudad Autonoma Beunos Aires
Local Institution - 0002, Sydney
Local Institution - 0114, Bowral
Local Institution - 0097, Linz
Local Institution - 0001, Woolloongabba
Local Institution - 0098, Wels
Local Institution - 0107, Córdoba
Local Institution - 0104, Salzburger
Local Institution - 0081, Mar del Plata
Local Institution - 0008, Viedma
Local Institution - 0067, Torino
Local Institution - 0084, The Bronx
Local Institution - 0031, Haidari
Local Institution - 0108, Marseille
Local Institution - 0062, Milan
Local Institution - 0106, Dijon
Local Institution - 0055, Madrid
Local Institution - 0096, Pamplona
Local Institution - 0057, Santander
Local Institution - 0063, Modena
Local Institution - 0065, Reggio Emilia
Local Institution - 0094, Herne
Local Institution - 0058, Valencia
Local Institution - 0042, Angers
Local Institution - 0105, Cologne
Local Institution - 0074, Ramat Gan
Local Institution - 0095, Trier
Local Institution - 0032, Thessaloniki
Local Institution - 0045, Lille
The University Of Chicago, Chicago
Local Institution - 0111, Paris
Local Institution - 0103, Paris
Local Institution - 0064, Napoli
Local Institution - 0040, Villejuif
Local Institution - 0051, Moscow
Local Institution - 0052, Saint Petersburg
Local Institution - 0011, La Serena
Local Institution - 0072, Viña del Mar
Local Institution - 0075, Tel Aviv
Local Institution - 0073, Jerusalem
Local Institution - 0050, Uberlândia
Local Institution - 0048, Porto Alegre
Local Institution - 0047, Itajaí
Local Institution - 0049, Rio de Janeiro
Local Institution - 0017, Toronto
Local Institution - 0038, Montreal
Local Institution - 0037, Montreal
Local Institution - 0012, Rimouski
Local Institution - 0041, Strasbourg
Local Institution - 0093, Jena
Local Institution - 0066, Roma
Local Institution - 0054, Arnhem
Local Institution, Rotterdam
Local Institution - 0061, Badajoz
Local Institution - 0060, Badalona-barcelona
Local Institution - 0059, Sabadell
Local Institution - 0087, Norrköping
Local Institution - 0083, Umeå
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY